TEVA – teva pharmaceutical industries limited american depositary shares (US:NASDAQ)
Stock Stats
News
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 17 Filed by: Sabag Mark
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Sabag Mark
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Sabag Mark
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Kalif Eliyahu Sharon
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Weiss Amir
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.